Buprenorphine Detoxification - BBDVI - 19
Phase 2
Completed
- Conditions
- Opioid-Related Disorders
- Registration Number
- NCT00000237
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Brief Summary
The purpose of this study is to examine the long-term efficacy of alternate-day dosing schedules in promoting treatment compliance in the absence of confounding behavioral contingencies.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Drug use Retention Weeks abstinent Weeks continuous abstinence Overall treatment outcome Opioid dependence and psychiatric status
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Treatment Research Center
🇺🇸Burlington, Vermont, United States
Treatment Research Center🇺🇸Burlington, Vermont, United States